Brooklyn Health

Founded in 2023 and headquartered in Brooklyn, US, Brooklyn Health specializes in developing solutions for mental health assessments.Brooklyn Health specializes in the development of innovative solutions aimed at modernizing mental health measurement, particularly through its flagship product, Willis, an electronic Clinical Outcome Assessment (eCOA) tool. This solution is designed to enhance the efficiency and accuracy of mental health assessments during clinical trials, thereby addressing significant challenges faced by researchers and healthcare providers in tracking patient outcomes. The primary end users of Brooklyn Health's offerings include pharmaceutical companies, clinical research organizations, and healthcare institutions engaged in mental health research. By providing a streamlined approach to data collection and analysis, Brooklyn Health aims to facilitate improved decision-making in clinical settings.Brooklyn Health generates revenue through a subscription-based model for its eCOA solution, Willis, catering to various stakeholders in the clinical trials ecosystem. Clients typically include pharmaceutical companies and clinical research organizations that require reliable tools for measuring mental health outcomes. Transactions are structured around annual or multi-year subscriptions, allowing clients to access the platform for data collection and analysis. Pricing plans are designed to accommodate the varying needs of different organizations, ensuring scalability and flexibility in their use of the platform. The company plans to enhance its product offerings and expand into new markets in North America and Europe by the end of 2025, focusing on regions with increasing demand for mental health research tools.

1. Seed

   May 27, 2025

   Amount

   $6.5M

   Investors

   Locked